All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @aymen_arbii on TikTok · 59s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @aymen_arbii's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:30The organized
  2. 0:31that's gonna be in the world
  3. 0:32does not make money
  4. 0:34but it is just a lot...
  5. 0:35...that's why we don't make money
  6. 0:37it's a lot of money
  7. 0:38and it's not made of
  8. 0:40a lot
  9. 0:41for the student
  10. 0:42organization
  11. 0:43that I watch
  12. 0:43on Instagram
  13. 0:44and to the next one
  14. 0:46the judge
  15. 0:47and worse
  16. 0:48and the other
  17. 0:49that I was talking about
  18. 0:51was that this is going to be
  19. 0:52the first thing
  20. 0:54to do
  21. 0:55and I noticed
  22. 0:56I have noticed
  23. 0:58that there's a lot
  24. 0:58that I saw
  25. 0:58a

@aymen_arbii's MK-677 post leaves out key safety issues

Aymen Arbi

TikTok creator

45.8K viewsWatch on TikTok

Quick answer

This TikTok promotes MK-677 (ibutamoren) in a bodybuilding context, but the spoken transcript contains no coherent clinical claims that can be evaluated. MK-677 is a ghrelin receptor agonist that raises GH and IGF-1 in documented trials, but it carries a known risk of insulin resistance, fluid retention, and increased appetite that is absent from the video's framing. It remains an unapproved research compound with no completed long-term safety data in humans.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @aymen_arbii's MK-677 post leaves out key safety issues, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@aymen_arbii's MK-677 post leaves out key safety issues is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@aymen_arbii's MK-677 post leaves out key safety issues" from Aymen Arbi. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: This TikTok promotes MK-677 (ibutamoren) in a bodybuilding context, but the spoken transcript contains no coherent clinical claims that can be evaluated.

The reason this review is not generic is the source wording and the canonical claim label "peptides mk 677 ibutamoren sk 777 mk677 gym bodybuildingmotivation." In this clip, the useful excerpt is: "The organized that's gonna be in the world does not make money but it is just a lot." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Nass et al.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

This TikTok promotes MK-677 (ibutamoren) in a bodybuilding context, but the spoken transcript contains no coherent clinical claims that can be evaluated.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • This TikTok promotes MK-677 (ibutamoren) in a bodybuilding context, but the spoken transcript contains no coherent clinical claims that can be evaluated. MK-677 is a ghrelin receptor agonist that raises GH and IGF-1 in documented trials, but it carries a known risk of insulin resistance, fluid retention, and increased appetite that is absent from the video's framing. It remains an unapproved research compound with no completed long-term safety data in humans.
  • MK-677 is not an FDA-approved drug. It is classified as a research chemical with no approved human indication as of 2024.
  • Nass et al. (2008, Annals of Internal Medicine) found lean mass improvements with MK-677 in adults aged 60 to 81, not in healthy young bodybuilders.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • MK-677 is not an FDA-approved drug. It is classified as a research chemical with no approved human indication as of 2024.
  • Nass et al. (2008, Annals of Internal Medicine) found lean mass improvements with MK-677 in adults aged 60 to 81, not in healthy young bodybuilders.
  • Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) confirmed MK-677 raises GH and IGF-1, but also noted increased fasting blood glucose and insulin resistance.
  • Murphy et al. (1998, European Journal of Endocrinology) documented transient cortisol elevation, appetite increases, and fluid retention as consistent side effects.
  • SK-777 is not a real compound name in any published pharmacological literature or regulatory database.
  • MK-677 is chemically a small molecule ghrelin receptor agonist, not a peptide, despite frequent mislabeling in fitness content.
  • No long-term human safety trial for MK-677 has been completed, meaning the risk profile beyond 12 months remains unknown.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @aymen_arbii actually say?

Honestly? It's hard to tell. The transcript from this 45,800-view TikTok is largely incoherent. Phrases like "the organized that's gonna be in the world does not make money" and "the judge and worse" don't map onto any identifiable claim about MK-677. The video's caption names MK-677 (ibutamoren) alongside the label "SK-777," which is not a recognized compound name in any pharmacological database.

Given the hashtags, the bodybuilding context, and the mention of MK-677 in the caption, it's reasonable to infer this video is promoting MK-677 for muscle gain or body recomposition. But the spoken content doesn't let us quote a specific health claim. That matters. A video with nearly 46,000 views that pushes an unscheduled research compound while offering no verifiable claim is its own kind of problem.

Does the science back this up?

MK-677 does have real pharmacology behind it, though the gap between what the research shows and what gym influencers claim is significant. The compound is a ghrelin receptor agonist and oral growth hormone secretagogue, meaning it stimulates the pituitary to release growth hormone rather than supplying exogenous GH directly.

A study by Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) confirmed MK-677 elevates GH and IGF-1 levels in healthy adults. Nass et al. (2008, Annals of Internal Medicine) found modest improvements in lean body mass in older adults. These are real findings. However, both studies also flagged increased fasting glucose, insulin resistance, and water retention as common side effects. A long-term safety trial has never been completed. MK-677 has not been approved by the FDA for any indication and remains a research chemical. Framing it casually in a bodybuilding TikTok strips out that entire risk profile.

What did they get wrong (or right)?

We can't credit or correct specific spoken claims here because the transcript doesn't contain any coherent ones. What we can assess is the framing. Pairing "MK-677" with "SK-777" in the caption is either a typo or an invented compound name, neither of which builds confidence.

What the creator got implicitly wrong is context. MK-677 is not a peptide in the strict chemical sense. It's a non-peptide small molecule that mimics ghrelin. Grouping it with true peptides like BPC-157 or ipamorelin in the broader "peptide" category is technically inaccurate, though common in fitness communities. More importantly, promoting any GH secretagogue without discussing the insulin-resistance risk, the potential for increased cortisol, or the lack of long-term human data is irresponsible. Bodybuilders chasing lean mass gains from MK-677 may also be unknowingly worsening their metabolic markers.

What should you actually know?

MK-677 raises GH and IGF-1. That part is documented. But "raises GH" does not automatically translate to meaningful muscle gain in healthy, well-fed young adults, which is the primary audience for bodybuilding content. The Nass 2008 trial studied adults aged 60 to 81. Extrapolating those results to a 22-year-old gym-goer is speculative at best.

The side effect profile deserves equal attention. Increased appetite (significant, not trivial), fluid retention, elevated fasting blood glucose, and fatigue are consistently reported. Murphy et al. (1998, European Journal of Endocrinology) documented transient increases in cortisol. Anyone with pre-diabetes, insulin resistance, or a family history of type 2 diabetes should treat MK-677 with real caution, not a TikTok caption. If you're curious about GH optimization through legitimate channels, that conversation belongs with a licensed clinician reviewing your labs, not with a viral video that can't complete a sentence.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Aymen Arbi · TikTok creator

45.8K views on this video

MK-677 Ibutamoren SK-777 #mk677 #gym #bodybuildingmotivation #تضخيم #الشعب_الصيني_ماله_حل😂😂

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about mk-677?

MK-677 is not an FDA-approved drug. It is classified as a research chemical with no approved human indication as of 2024.

What does the video say about nass et al. (2008, annals of internal medicine) found lean?

Nass et al. (2008, Annals of Internal Medicine) found lean mass improvements with MK-677 in adults aged 60 to 81, not in healthy young bodybuilders.

What does the video say about svensson et al. (1998, journal of clinical endocrinology?

Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) confirmed MK-677 raises GH and IGF-1, but also noted increased fasting blood glucose and insulin resistance.

What does the video say about murphy et al. (1998, european journal of endocrinology) documented transient?

Murphy et al. (1998, European Journal of Endocrinology) documented transient cortisol elevation, appetite increases, and fluid retention as consistent side effects.

What does the video say about sk-777?

SK-777 is not a real compound name in any published pharmacological literature or regulatory database.

What does the video say about mk-677?

MK-677 is chemically a small molecule ghrelin receptor agonist, not a peptide, despite frequent mislabeling in fitness content.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Aymen Arbi, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.